[177Lu]Lu-DFC413

Lutetium-177-labeled DFC413 · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for [177Lu]Lu-DFC413, covering 2026-04-21 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors [Phase 1]